drugset / Trial / NCT00003348

Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain

NCT00003348

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of carmustine plus O(6)-benzylguanine in treating patients who have recurrent or progressive gliomas of the brain.

Timeline

Start
1998-05
Primary completion
2000-08
Completion
2000-08

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule Intravenous
Background O6-benzylguanine Small molecule Intravenous